Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Pioglitazone and Metformin Combination Therapy in Treating Type 2 Diabetes Mellitus.

ClinicalTrials.gov ID: NCT00727857

Public ClinicalTrials.gov record NCT00727857. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 11, 2026, 4:48 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3b, Double-Blind, Randomized Study to Determine the Efficacy and Safety of Pioglitazone HCl and Metformin HCl Fixed-Dose Combination Therapy Compared to Pioglitazone HCl Monotherapy and to Metformin HCl Monotherapy in the Treatment of Subjects With Type 2 Diabetes

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine the efficacy of pioglitazone, twice daily (BID), combined with metformin versus pioglitazone taken alone and metformin taken alone in treating Type 2 Diabetes Mellitus.

Study identification

NCT ID
NCT00727857
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Takeda
Industry
Enrollment
600 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2007
Primary completion
Jul 31, 2008
Completion
Jul 31, 2008
Last update posted
Jul 28, 2011

2007 – 2008

United States locations

U.S. sites
66
U.S. states
27
U.S. cities
66
Facility City State ZIP Site status
Not listed Birmingham Alabama
Not listed Haleyville Alabama
Not listed Montgomery Alabama
Not listed Pell City Alabama
Not listed Phoenix Arizona
Not listed Tucson Arizona
Not listed Anaheim California
Not listed Artesia California
Not listed Dinuba California
Not listed Long Beach California
Not listed Los Angeles California
Not listed Norwalk California
Not listed Orange California
Not listed Santa Ana California
Not listed Santa Monica California
Not listed Pueblo Colorado
Not listed Altamonte Springs Florida
Not listed Coral Gables Florida
Not listed Hialeah Florida
Not listed Miami Florida
Not listed Panama City Florida
Not listed Plantation Florida
Not listed Saint Cloud Florida
Not listed St. Petersburg Florida
Not listed Tampa Florida
Not listed Columbus Georgia
Not listed Boise Idaho
Not listed Coeur d'Alene Idaho
Not listed Chicago Illinois
Not listed Flossmoor Illinois
Not listed Peoria Illinois
Not listed Elkhart Indiana
Not listed Shawnee Kansas
Not listed Southfield Michigan
Not listed Chesterfield Missouri
Not listed Billings Montana
Not listed Elizabeth New Jersey
Not listed Fayetteville New York
Not listed New York New York
Not listed Durham North Carolina
Not listed Pinehurst North Carolina
Not listed Cincinnati Ohio
Not listed Perrysburg Ohio
Not listed Zanesville Ohio
Not listed Oklahoma City Oklahoma
Not listed Eugene Oregon
Not listed Fleetwood Pennsylvania
Not listed Norristown Pennsylvania
Not listed Cranston Rhode Island
Not listed Simpsonville South Carolina
Not listed Varnville South Carolina
Not listed Fayetteville Tennessee
Not listed Corpus Christi Texas
Not listed Dallas Texas
Not listed El Paso Texas
Not listed Houston Texas
Not listed McAllen Texas
Not listed Mission Texas
Not listed New Braunfels Texas
Not listed North Richland Hills Texas
Not listed San Antonio Texas
Not listed Bountiful Utah
Not listed Salt Lake City Utah
Not listed Petersburg Virginia
Not listed Port Orchard Washington
Not listed Spokane Washington

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00727857, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 28, 2011 · Synced Sep 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00727857 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →